title: Noradrenergic responses to clonidine in acute and remitted depressed male patients.
abstract: To investigate noradrenergic function in depression, plasma 3-methoxy-4-hydroxyphenylglycol (MHPG), plasma norepinephrine (NE), mean arterial pressure (MAP), and heart rate responses to intravenous clonidine (2 micrograms/kg), an alpha 2-adrenergic agonist, were measured in 27 acutely depressed patients, 18 remitted depressed patients, and 27 normal control subjects; a placebo infusion was administered to a subgroup. Clonidine compared with placebo, over a 150-minute time course, decreased plasma NE, MAP, and heart rate, but not plasma MHPG, in the control subjects. Plasma MHPG, plasma NE, MAP, and heart rate at baseline or in response to clonidine and placebo over 150 minutes did not indicate any group differences. The only significant plasma MHPG response to clonidine in the normal control subjects occurred 60 minutes after the infusion. A significantly diminished plasma MHPG response to clonidine at 60 minutes was found in the acutely depressed group compared with the normal control subjects. These results suggest that peripheral inhibitory noradrenergic responses to clonidine are normal in depressed patients, while plasma MHPG responses to clonidine, which have a limited central contribution, appear to be a weak reflection of central noradrenergic function and appear insufficiently robust for a meaningful evaluation of hypothetical group differences in central inhibitory alpha 2-adrenergic activity in this population.
authors.affiliation: Bronx VA Medical Center, NY 10468.
authors.forename: R L
authors.initials: RL
authors.lastname: Trestman
authors.forename: T L
authors.initials: TL
authors.lastname: Lawrence
authors.forename: E F
authors.initials: EF
authors.lastname: Coccaro
authors.forename: P
authors.initials: P
authors.lastname: Harvey
authors.forename: D
authors.initials: D
authors.lastname: Bernstein
authors.forename: E K
authors.initials: EK
authors.lastname: Lawrence
authors.forename: V
authors.initials: V
authors.lastname: Condello
authors.forename: T
authors.initials: T
authors.lastname: Mahon
authors.forename: R K
authors.initials: RK
authors.lastname: Yang
authors.forename: P
authors.initials: P
authors.lastname: Knott
mesh_terms: D000208:Acute Disease; D000368:Aged; D001143:Arousal / Q000187:drug effects / Q000502:physiology*; D001714:Bipolar Disorder / Q000097:blood* / Q000175:diagnosis / Q000523:psychology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D003000:Clonidine; D015331:Cohort Studies; D003866:Depressive Disorder / Q000097:blood* / Q000175:diagnosis / Q000523:psychology; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000097:blood; D008875:Middle Aged; D009638:Norepinephrine / Q000502:physiology*; D011941:Receptors, Adrenergic / Q000187:drug effects / Q000502:physiology*
chemical_list: D011941:Receptors, Adrenergic; D008734:Methoxyhydroxyphenylglycol; D003000:Clonidine; D009638:Norepinephrine